The tweet was deleted by the author.
But we saved everything 🙂.
Emergent Biosolutions has reaffirmed its commitment to bolstering protection for Americans by enhancing preparedness strategies against potential biological threats.
The company stated that addressing today's health challenges is integral to building a safer future. Emergent Biosolutions continues to focus on its mission to protect and save lives through readiness and proactive measures in public health defense. Details are being clarified.
Emergent Biosolutions recently evaluated the safety and pharmacokinetics of multi-dose intranasal naloxone in ongoing research focused on opioid overdose response, according to a recent publication. The company also partnered to support Madagascar's first enrollment in a MpOx Study as the country confronted a new mpox outbreak, as reported in an earlier announcement. These initiatives reflect Emergent's continued activity in public health preparedness.